Vesicular flavonoid in combating diethylnitrosamine induced hepatocarcinoma in rat model

Journal of Experimental Therapeutics and Oncology

Volumn 7, Issue 2, 2008, Pages 123-133

  Mandal, Ardhendu K ^a   Das, Sanchari ^a   Mitra, Maitreyi ^a   Chakrabarti, Rohini N ^b   Chatterjee, Malay ^c   Das, Nirmalendu ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Ashok Laboratory   (India)

^c JADAVPUR UNIVERSITY   (India)

Author keywords

Diethylnitrosamine; Galactosylated liposomal Quercetin; Hepatocarcinoma; Oxidative damage; Reactive oxygen species

Indexed keywords

DIETHYLNITROSAMINE; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ELECTRON MICROSCOPY; HISTOPATHOLOGY; LIPOSOMAL DELIVERY; LIVER CELL CARCINOMA; LIVER INJURY; LIVER NODULE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUSPENSION;

ALKYLATING AGENTS; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CARCINOGENS; CATALASE; DIETHYLNITROSAMINE; DRUG CARRIERS; DRUG COMPOUNDING; GALACTOSE; GLUTATHIONE PEROXIDASE; INTERCALATING AGENTS; LIPID PEROXIDATION; LIPOSOMES; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICROSCOPY, ELECTRON; MICROSOMES, LIVER; ORGAN SIZE; QUERCETIN; RATS;

EID: 49549088571     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Babbar N, Casero RA Jr. Tumor necrosis factor-alpha increases reactive oxygenspecies by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis. Cancer Res 66: 11125-11130, 2006.
2. Chen C, Kong AN. Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. Trends Pharmacol Sci 26:318-326, 2005.
3. Pervin S, Sing R, Hernandez E, Wu G, Chaudhuri G. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/ elF4E pathway. Cancer Res 67: 289-299, 2007.
4. Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-4540 (P-450IIE1). Biochem Pharmacol 38: 1313-1319, 1989.
5. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44: 239-267, 2004.
6. Elattar TM, Virji AS. The inhibitory effect of curcumin, genistein, quercetin and cisplantin on the growth of oral cancer cells in vitro. Anticancer Res 20: 1733-1738, 2000.
7. Mitra M, Mandal AK, Chatterjee TK, Das N. Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis. J Drug Target 13: 285-293, 2005.
8. Sinha J, Das N, Basu MK. Targeting of glycoside grafted liposomes to specific hepatocellular sites. J Surface Sci Technol 16: 200-209, 2000.
9. Budai M, Szoqvi M. Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes. Acta Pharm Hung 71: 114-118, 2001.
10. Mandal AK, Das N. Sugar coated liposomal flavonoid: A unique formulation in combating carbontetrachloride induced hepatic oxidative damage. J Drug Target 13: 305-315, 2005.
11. Tyagi R, Lala S, Verma AK, Nandy AK, Mahato SB, Maitra A, Basu MK. Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis. J Drug Target 13: 161-171, 2005.
12. Karim S, Bhandari U, Kumar H, Salam A, Siddiqui MAA, Pillai KK. Doxorubicin induced cardiotoxicity and its modulation by drugs. Ind J Pharm 33: 203-207, 2001.
13. Kim SW, Park KC, Kim HJ, Cho KH, Chung JH, Kim KH, Eun HC, Lee JS, Park KD. Effects of collagen IV and laminin on the reconstruction of human oral mucosa. J Biomed Mater Res 58: 108-112, 2001.
14. Chowdhury AR, Mandal S, Goswami A, Ghosh M, Mandal L, Chakraborty D, Ganguly A, Tripathi G, Mukhopadhyay S, Bandyopadhyay S, Majumder HK. Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy. Mol Med 9: 26-36, 2003.
15. Mandal AK, Sinha J, Mandal S, Mukhopadhyay S, Das N. Targeting of liposomal flavonoid to liver in combating hepatocellular oxidative damage. Drug Deliv 9: 181-185, 2002.
16. Sarkar S, Das N. Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain. Mech Age Develop 127: 391-397, 2006.
17. Moragon AC, De Lucas Garcia N, Encarnacion Lopez Fernandez M, Rodriguez-Manzaneque AS, Jimenez Fraile JA. Antioxidant enzymes, occupational stress and burnout in workers of a prehospitalary emergency service. Eur J Emerg Med 12: 111-115, 2005.
18. Maiti S, Chatterjee AK. Differential response of cellular antioxidant mechanism of liver and kidney to arsenic exposure and its relation to dietary protein deficiency. Environ Tox Pharm 8: 227-235, 2000.
19. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 475: 7-20, 2001.
20. Hofseth LJ, Hussain SP, Wogan GN, Harris CC. Nitric oxide in cancer and chemoprevention 1. Free Radic Biol Med 34: 955-968, 2003.
21. Crowell JA, Steele VE, Sigman CC, Fay JR. Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther 2: 815-23, 2003.
22. Psahoulia FH, Moumtzi S, Roberts ML, Sasazuki T, Shirasawa S, Pintzas A. Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells. Carcinogenesis 28: 1021-1031, 2007.
23. Sharma RA, Gescher AJ, Steward WP. Curcumin: The story so far. Eur J Cancer 41: 1955-1968, 2005.
24. Datta N, Mukherjee S, Das L, Das PK. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up regulation and T-cell activation. Eur J Immunol 33: 1508-1518, 2003.
25. Kawakami S, Munakata C, Fumoto S, Yamashita F, Hashida M. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs. J Pharm Sci 90: 105-113, 2001.
26. Mandal AK, Das S, Basu MK, Chakrabarti RN, Das N. Hepatoprotective activity of liposomal flavonoid against arsenite-induced liver fibrosis. J Pharmacol Exp Ther 320: 994-1001, 2007.
27. Zhi-Ping Y, Li-Juan C, Lin-Yu F, Ming-Hai T, Guang-Li Y, Han-Su Y, Xiao-Bo D, Guo-Qing W, Wen-Xiu Y, Qu-Mei Z, Bin Y, Rui W, Peng D, Wei Z, Hong-bin W, Xia Z, Yu-Quan W. Liposomal Quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res 12: 3193-3199, 2006.